Aura Biosciences insider plans sale of 1,581 shares

Aura Biosciences insider Amy Elazzouzi has filed a Form 144 indicating an intention to sell up to 1,581 shares of the company’s common stock through broker Morgan Stanley Smith Barney LLC on or about 01/20/2026.

Rhea-AI Filing Summary

Aura Biosciences insider Amy Elazzouzi has filed a Form 144 indicating an intention to sell up to 1,581 shares of the company’s common stock through broker Morgan Stanley Smith Barney LLC on or about 01/20/2026. The filing lists an aggregate market value of $7,683.66 for this planned sale, with 63,503,269 shares of common stock outstanding and the stock listed on Nasdaq.

The securities to be sold were originally acquired as a restricted stock unit award granted on 01/19/2023 under Aura Biosciences’ 2021 Stock Option and Incentive Plan, in an amount of 2,844 shares. Over the past three months, the same seller has sold 896 shares of common stock for gross proceeds of $5,689.60. By signing the notice, the seller represents they are not aware of undisclosed material adverse information about Aura Biosciences.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Aura Biosciences (AURA) Form 144 filing disclose?

The Form 144 shows that Amy Elazzouzi plans to sell up to 1,581 shares of Aura Biosciences common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of $7,683.66, and that the stock is listed on Nasdaq.

How many Aura Biosciences shares are being registered for potential sale?

The notice covers a planned sale of 1,581 shares of Aura Biosciences common stock, with an indicated aggregate market value of $7,683.66.

How were the Aura Biosciences shares to be sold originally acquired?

The shares to be sold come from a restricted stock unit award of 2,844 shares granted on 01/19/2023 under Aura Biosciences’ 2021 Stock Option and Incentive Plan.

What prior Aura Biosciences stock sales by this insider are disclosed?

Over the past three months, the filing reports that Amy Elazzouzi sold 896 shares of Aura Biosciences common stock on 10/29/2025 for gross proceeds of $5,689.60.

How many Aura Biosciences shares are outstanding according to this filing?

The Form 144 states that 63,503,269 shares of Aura Biosciences common stock are outstanding.

What representations does the seller make in this Aura Biosciences Form 144?

By signing the notice, the seller represents that they do not know any material adverse information about Aura Biosciences’ current or prospective operations that has not been publicly disclosed and acknowledges the criminal penalties for intentional misstatements.

Which broker is handling the planned Aura Biosciences share sale?

The planned sale of 1,581 Aura Biosciences common shares is listed as being through Morgan Stanley Smith Barney LLC, with trading on the Nasdaq exchange.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/20/2026 - 06:42 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002042910
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Aura Biosciences, Inc.
SEC File Number	001-40971
Address of Issuer	80 Guest Street Boston MASSACHUSETTS 02135
Phone	617-500-8864
Name of Person for Whose Account the Securities are To Be Sold	Elazzouzi Amy
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Morgan Stanley Smith Barney LLC Drive 200 West Civic Center 4th Floor Sandy UT 84070	1581	7683.66	63503269	01/20/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	01/19/2023	Restricted Stock unit award granted pursuant to the Issuer's 2021 Stock Option and Incentive Plan, subject to vesting requirements.	Aura Biosciences, Inc.			2844	01/19/2023	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Amy Elazzouzi 80 Guest Street Boston MA 02135	Common Stock	10/29/2025	896	5689.60

144: Remarks and Signature

Remarks	The sales reported on this Form 144 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.
Date of Notice	01/20/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Amy Elazzouzi
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)